Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$78.08

0.5 (0.64%)

, ALKS

Alkermes

$33.13

1.19 (3.73%)

08:00
03/12/19
03/12
08:00
03/12/19
08:00
Conference/Events
Cowen to hold a conference »

39th Annual Healthcare…

ABBV

AbbVie

$78.08

0.5 (0.64%)

ALKS

Alkermes

$33.13

1.19 (3.73%)

BLUE

Bluebird Bio

$147.11

8.38 (6.04%)

AMGN

Amgen

$184.16

3.29 (1.82%)

CDXS

Codexis

$20.33

0.95 (4.90%)

MGNX

MacroGenics

$19.76

0.42 (2.17%)

BMRN

BioMarin

$91.25

1.28 (1.42%)

QURE

uniQure

$65.34

2.97 (4.76%)

MDCO

The Medicines Co.

$25.49

0.32 (1.27%)

SGEN

Seattle Genetics

$71.11

1.87 (2.70%)

TWST

Twist Bioscience

$21.79

0.73 (3.47%)

TXMD

TherapeuticsMD

$5.53

-0.175 (-3.07%)

NVTR

Nuvectra

$12.30

0.44 (3.71%)

ALXN

Alexion

$132.02

3.3 (2.56%)

AKAO

Achaogen

$0.63

-0.0138 (-2.15%)

ARRY

Array BioPharma

$22.74

0.93 (4.26%)

PODD

Insulet

$94.00

2 (2.17%)

JAZZ

Jazz Pharmaceuticals

$132.99

0.47 (0.35%)

PDLI

PDL BioPharma

$3.49

-0.06 (-1.69%)

XOMA

Xoma

$14.83

0.01 (0.07%)

TNDM

TNDM

NUVA

NuVasive

$58.70

0.61 (1.05%)

RHHBY

Roche

$0.00

(0.00%)

PBYI

Puma Biotechnology

$40.13

1.93 (5.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 12

    Mar

  • 12

    Mar

  • 14

    Mar

  • 18

    Mar

  • 19

    Mar

  • 20

    Mar

  • 20

    Mar

  • 04

    Apr

  • 16

    Apr

  • 18

    May

  • 28

    May

  • 28

    Jun

  • 19

    Aug

  • 04

    Nov

ALKS

Alkermes

$34.26

0.86 (2.57%)

07:15
02/26/19
02/26
07:15
02/26/19
07:15
Hot Stocks
Alkermes initiates clinical study of ALKS 4230 »

Alkermes announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$33.40

0.84 (2.58%)

, BIIB

Biogen

$325.32

4.33 (1.35%)

07:44
02/25/19
02/25
07:44
02/25/19
07:44
Hot Stocks
Alkermes, Biogen announce FDA acceptance of diroximel fumarate NDA for review »

Alkermes (ALKS) and…

ALKS

Alkermes

$33.40

0.84 (2.58%)

BIIB

Biogen

$325.32

4.33 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

ALKS

Alkermes

$33.40

0.84 (2.58%)

, BIIB

Biogen

$325.32

4.33 (1.35%)

07:38
02/25/19
02/25
07:38
02/25/19
07:38
Hot Stocks
Alkermes, Biogen: FDA accepts for review NDA for diroximel fumarate »

Alkermes (ALKS) and…

ALKS

Alkermes

$33.40

0.84 (2.58%)

BIIB

Biogen

$325.32

4.33 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

ALKS

Alkermes

$32.52

(0.00%)

, CLVS

Clovis

$25.44

(0.00%)

07:02
02/19/19
02/19
07:02
02/19/19
07:02
Hot Stocks
Alkermes and Clovis announce research collaboration to evaluate ALKS 4230 »

Alkermes (ALKS) and…

ALKS

Alkermes

$32.52

(0.00%)

CLVS

Clovis

$25.44

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ALKS

Alkermes

$32.52

-0.43 (-1.31%)

09:20
02/15/19
02/15
09:20
02/15/19
09:20
Recommendations
Alkermes analyst commentary at Stifel »

Alkermes price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$40.00

13 (8.00%)

16:44
02/14/19
02/14
16:44
02/14/19
16:44
Recommendations
Alkermes analyst commentary at Piper Jaffray »

Piper Jaffray sees impact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

ALKS

Alkermes

$32.95

0.64 (1.98%)

08:55
02/14/19
02/14
08:55
02/14/19
08:55
Hot Stocks
Alkermes to determine future of ALKS 5461 after talks with FDA »

Alkermes needs additional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

ALKS

Alkermes

$32.95

0.64 (1.98%)

07:12
02/14/19
02/14
07:12
02/14/19
07:12
Hot Stocks
Alkermes CEO sees 2019 as important year for late-stage pipeline »

"Alkermes is defined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

ALKS

Alkermes

$32.95

0.64 (1.98%)

, BIIB

Biogen

$321.46

2.03 (0.64%)

07:11
02/14/19
02/14
07:11
02/14/19
07:11
Earnings
Alkermes sees FY19 EPS 25c-43c, consensus 56c »

Sees FY19 revenue…

ALKS

Alkermes

$32.95

0.64 (1.98%)

BIIB

Biogen

$321.46

2.03 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.